182 related articles for article (PubMed ID: 31736874)
1. Preoperative Fasting C-Peptide Acts as a Promising Predictor of Improved Glucose Tolerance in Patients With Acromegaly After Transsphenoidal Surgery: A Retrospective Study of 64 Cases From a Large Pituitary Center in China.
Wang Z; Gao L; Guo X; Feng C; Deng K; Lian W; Feng M; Bao X; Xing B
Front Endocrinol (Lausanne); 2019; 10():736. PubMed ID: 31736874
[No Abstract] [Full Text] [Related]
2. Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases.
He W; Yan L; Wang M; Li Q; He M; Ma Z; Ye Z; Zhang Q; Zhang Y; Qiao N; Lu Y; Ye H; Lu B; Shou X; Zhao Y; Li Y; Li S; Zhang Z; Shen M; Wang Y
Endocrine; 2019 Jan; 63(1):27-35. PubMed ID: 30238327
[TBL] [Abstract][Full Text] [Related]
3. Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: correlation with serum IGF-I levels.
Mori K; Iwasaki Y; Kawasaki-Ogita Y; Honjo S; Hamamoto Y; Tatsuoka H; Fujimoto K; Ikeda H; Wada Y; Takahashi Y; Takahashi J; Koshiyama H
J Endocrinol Invest; 2013 Nov; 36(10):853-9. PubMed ID: 23665535
[TBL] [Abstract][Full Text] [Related]
4. Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China.
Li YL; Zhang S; Guo XP; Gao L; Lian W; Yao Y; Deng K; Wang RZ; Xing B
Arch Endocrinol Metab; 2019; 63(2):157-166. PubMed ID: 30916168
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Abnormal Glucose Metabolism in Acromegaly and Impact of Treatment Modalities on Glucose Metabolism.
Khan SA; Ram N; Masood MQ
Cureus; 2021 Mar; 13(3):e13852. PubMed ID: 33859902
[TBL] [Abstract][Full Text] [Related]
6. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
[TBL] [Abstract][Full Text] [Related]
7. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
Serri O; Beauregard C; Hardy J
J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
[TBL] [Abstract][Full Text] [Related]
8. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
9. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
10. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S; Jacob KS; Pratheesh R; Chacko AG
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[TBL] [Abstract][Full Text] [Related]
11. Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly.
Jaffrain-Rea ML; Minniti G; Moroni C; Esposito V; Ferretti E; Santoro A; Infusino T; Tamburrano G; Cantore G; Cassone R
Eur J Endocrinol; 2003 Feb; 148(2):193-201. PubMed ID: 12590638
[TBL] [Abstract][Full Text] [Related]
12. Effect of Transsphenoidal Adenectomy on Glucose Tolerance Status in Patients with Growth Hormone-secreting Pituitary Adenoma.
Li YL; Zhang S; Guo XP; Gao L; Lian W; Wang RZ; Xing B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):73-7. PubMed ID: 26956860
[TBL] [Abstract][Full Text] [Related]
13. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
[TBL] [Abstract][Full Text] [Related]
14. Disposition Index in Active Acromegaly.
Niculescu DA; Dusceac R; Caragheorgheopol A; Popescu N; Poiana C
Front Endocrinol (Lausanne); 2019; 10():637. PubMed ID: 31620090
[No Abstract] [Full Text] [Related]
15. Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
Feelders RA; Bidlingmaier M; Strasburger CJ; Janssen JA; Uitterlinden P; Hofland LJ; Lamberts SW; van der Lely AJ; de Herder WW
J Clin Endocrinol Metab; 2005 Dec; 90(12):6480-9. PubMed ID: 16159936
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
Starke RM; Raper DM; Payne SC; Vance ML; Oldfield EH; Jane JA
J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of abnormal glucose tolerance and its resolution in acromegaly: Single Centre retrospective study of 90 cases.
Khaire SS; Gada JV; Varthakavi PK; Bhagwat NM
Growth Horm IGF Res; 2021 Aug; 59():101394. PubMed ID: 33984540
[TBL] [Abstract][Full Text] [Related]
18. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
19. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
20. Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study.
Shen M; Wang M; He W; He M; Qiao N; Ma Z; Ye Z; Zhang Q; Zhang Y; Yang Y; Cai Y; ABuDuoReYiMu Y; Lu Y; Lu B; Shou X; Wang Y; Ye H; Li Y; Li S; Zhao Y; Cao X; Zhang Z
Int J Endocrinol; 2018; 2018():3015854. PubMed ID: 29853879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
